• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Patterns of Factors in the National Institute on Aging Health Disparities Research Framework Domains and Mild Cognitive Impairment Risk.美国国立衰老研究所健康差异研究框架领域中的因素模式与轻度认知障碍风险
AJPM Focus. 2025 Feb 17;4(3):100324. doi: 10.1016/j.focus.2025.100324. eCollection 2025 Jun.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study.基线神经精神症状与轻度认知障碍发病风险:一项基于人群的研究。
Am J Psychiatry. 2014 May;171(5):572-81. doi: 10.1176/appi.ajp.2014.13060821.
4
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.NIA-AA 研究框架:迈向阿尔茨海默病的生物学定义。
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.
5
12-year prediction of mild cognitive impairment aided by Alzheimer's brain signatures at mean age 56.基于平均年龄56岁时阿尔茨海默病脑特征对轻度认知障碍的12年预测
Brain Commun. 2021 Jul 23;3(3):fcab167. doi: 10.1093/braincomms/fcab167. eCollection 2021.
6
Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.血清中维生素 E 形态水平与芬兰老年人群认知障碍风险的关系。
Exp Gerontol. 2013 Dec;48(12):1428-35. doi: 10.1016/j.exger.2013.09.006. Epub 2013 Oct 7.
7
Association between hearing loss and development of dementia using formal behavioural audiometric testing within the Mayo Clinic Study of Aging (MCSA): a prospective population-based study.使用 Mayo 诊所老龄化研究(MCSA)中的正式行为听力测试评估听力损失与痴呆发展之间的关系:一项前瞻性基于人群的研究。
Lancet Healthy Longev. 2022 Dec;3(12):e817-e824. doi: 10.1016/S2666-7568(22)00241-0. Epub 2022 Nov 18.
8
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
9
Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study.细胞衰老生物标志物可预测轻度认知障碍风险:老年生活方式干预(LIFE)研究结果
J Nutr Health Aging. 2025 May;29(5):100529. doi: 10.1016/j.jnha.2025.100529. Epub 2025 Mar 7.
10
Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging.体重下降与轻度认知障碍的发生:梅奥诊所衰老研究
JAMA Neurol. 2016 Apr;73(4):439-46. doi: 10.1001/jamaneurol.2015.4756.

本文引用的文献

1
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission.《痴呆症的预防、干预与照护:柳叶刀常设委员会2024年报告》
Lancet. 2024 Aug 10;404(10452):572-628. doi: 10.1016/S0140-6736(24)01296-0. Epub 2024 Jul 31.
2
Poor self-rated health is associated with faster cognitive decline and greater small vessel disease in older adults with type 2 diabetes.自评健康状况较差与 2 型糖尿病老年患者认知能力下降更快和小血管疾病更严重相关。
Diabetes Metab Res Rev. 2024 Jan;40(1):e3761. doi: 10.1002/dmrr.3761.
3
Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population.美国医疗保险人群初级保健中轻度认知障碍的检出率。
J Prev Alzheimers Dis. 2024;11(1):7-12. doi: 10.14283/jpad.2023.131.
4
Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis.美国医疗保险人群中轻度认知障碍和痴呆的预期和诊断率:观察性分析。
Alzheimers Res Ther. 2023 Jul 22;15(1):128. doi: 10.1186/s13195-023-01272-z.
5
Dementia Risk and Disadvantaged Neighborhoods.痴呆风险与不利社区。
JAMA Neurol. 2023 Sep 1;80(9):903-909. doi: 10.1001/jamaneurol.2023.2120.
6
The structural and social determinants of Alzheimer's disease related dementias.阿尔茨海默病相关痴呆的结构和社会决定因素。
Alzheimers Dement. 2023 Jul;19(7):3171-3185. doi: 10.1002/alz.13027. Epub 2023 Apr 19.
7
Social connectedness and cognitive decline.社交联系与认知衰退。
Lancet Healthy Longev. 2022 Nov;3(11):e723-e724. doi: 10.1016/S2666-7568(22)00217-3. Epub 2022 Oct 20.
8
Associations between social connections and cognition: a global collaborative individual participant data meta-analysis.社会关系与认知之间的关联:一项全球性合作的个体参与者数据荟萃分析。
Lancet Healthy Longev. 2022 Nov;3(11):e740-e753. doi: 10.1016/S2666-7568(22)00199-4. Epub 2022 Oct 20.
9
Evaluating Social Determinants of Health Domains and Their Predictive Validity Within Black/African American and White Older Adults From the ACTIVE Trial.评估来自“积极试验”的黑人/非裔美国人和白人老年人健康领域的社会决定因素及其预测效度。
J Aging Health. 2023 Oct;35(9_suppl):11S-18S. doi: 10.1177/08982643221111205. Epub 2022 Dec 2.
10
Association of neighborhood socioeconomic disadvantage and cognitive impairment.社区社会经济劣势与认知障碍的关联。
Alzheimers Dement. 2023 Mar;19(3):761-770. doi: 10.1002/alz.12702. Epub 2022 Jun 6.

美国国立衰老研究所健康差异研究框架领域中的因素模式与轻度认知障碍风险

Patterns of Factors in the National Institute on Aging Health Disparities Research Framework Domains and Mild Cognitive Impairment Risk.

作者信息

Vassilaki Maria, Aakre Jeremiah A, Lesnick Timothy G, Kremers Walter K, Graff-Radford Jonathan, Knopman David S, Mosley Thomas H, Windham B Gwen, Griswold Michael E, Geda Yonas E, Lowe Val J, Jack Clifford R, Petersen Ronald C, Vemuri Prashanthi

机构信息

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.

Department of Neurology, Mayo Clinic, Rochester, Minnesota.

出版信息

AJPM Focus. 2025 Feb 17;4(3):100324. doi: 10.1016/j.focus.2025.100324. eCollection 2025 Jun.

DOI:10.1016/j.focus.2025.100324
PMID:40225700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11987652/
Abstract

INTRODUCTION

Alzheimer's disease and related dementias are public health and social care challenges. This study used the National Institute on Aging Health Disparities Research Framework to organize potential cognitive impairment risk factors. It aimed to examine patterns of environmental, sociocultural, behavioral, and biological factors and identify key components that predict mild cognitive impairment risk.

METHODS

This study comprised 2,812 participants from the Mayo Clinic Study of Aging who were cognitively unimpaired at baseline (aged ≥50 years, mean age [SD]=68.9 [9.7] years, 50.4% female). Analyses utilized a 2-stage approach using factor and principal component analyses to group factors from multiple National Institute on Aging Health Disparities Research Framework domains and identify components that predict cognitive impairment risk. Using a cohort study design, the resulting composite scores were considered as covariates for incident mild cognitive impairment analysis using Cox proportional hazards models.

RESULTS

Three principal components explained 40.30% of the variance and were differentially associated with mild cognitive impairment risk. One component (Principal Component 2), which included factors from all 4 domains of the National Institute on Aging Health Disparities Research Framework (including social, group, and playing game activities [sociocultural domain]; exercise and physical activity [behavioral domain]; education/occupation [environmental domain]; and absence of cardiometabolic risk factors/health self-rating [biological domain]), was associated with lower mild cognitive impairment risk (hazard ratio=0.80, 95% CI=0.73, 0.89). The other 2 principal components, also including factors from multiple framework domains, were associated with increased mild cognitive impairment risk.

CONCLUSIONS

Derived principal components included factors from multiple framework domains, supporting the multietiology pathways leading to cognitive impairment. These principal components were differentially associated with mild cognitive impairment risk. Identifying key factors from multiple National Institute on Aging Health Disparities Research Framework domains associated with cognitive impairment risk has implications for effectively targeting interventions at multiple levels (e.g., medical, societal, policy) to avert or delay cognitive impairment risk.

摘要

引言

阿尔茨海默病及相关痴呆症是公共卫生和社会护理领域面临的挑战。本研究采用美国国立衰老研究所健康差异研究框架来梳理潜在的认知障碍风险因素。其目的是研究环境、社会文化、行为和生物因素的模式,并确定预测轻度认知障碍风险的关键因素。

方法

本研究纳入了梅奥诊所衰老研究中的2812名参与者,他们在基线时认知功能正常(年龄≥50岁,平均年龄[标准差]=68.9[9.7]岁,女性占50.4%)。分析采用两阶段方法,使用因子分析和主成分分析对来自美国国立衰老研究所健康差异研究框架多个领域的因素进行分组,并确定预测认知障碍风险的因素。采用队列研究设计,将所得的综合得分作为协变量,使用Cox比例风险模型进行新发轻度认知障碍分析。

结果

三个主成分解释了40.30%的方差,且与轻度认知障碍风险存在差异关联。其中一个主成分(主成分2),包括来自美国国立衰老研究所健康差异研究框架所有四个领域的因素(包括社交、群体和游戏活动[社会文化领域];锻炼和体育活动[行为领域];教育/职业[环境领域];以及无心血管代谢危险因素/健康自评[生物领域]),与较低的轻度认知障碍风险相关(风险比=0.80,95%置信区间=0.73,0.89)。另外两个主成分,也包括来自多个框架领域的因素,与较高的轻度认知障碍风险相关。

结论

推导得出的主成分包括来自多个框架领域的因素,支持了导致认知障碍的多病因途径。这些主成分与轻度认知障碍风险存在差异关联。确定来自美国国立衰老研究所健康差异研究框架多个领域的与认知障碍风险相关的关键因素,对于在多个层面(如医疗、社会、政策)有效实施干预措施以避免或延缓认知障碍风险具有重要意义。